Human Growth Hormone
Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue.
IGF1 Clinical Comparison with Human Growth Hormone
Endocrinologist Access in Rural Communities
Adverse Events with Human Growth Hormone
Impact of Varying Indications Among Human Growth Hormone Agents
Diagnosis of Hormone Deficiency in Adults and Appropriateness of Prescribing
Clinical Differentiation Between Therapies
Other Differentiators Between Human Growth Hormone Therapies: Device and Ease of Use
Impact of Pen vs. Vial in Formulary Decision Making
Financial Considerations Related to Pens vs. Vials: Saizen and Tev-Tropin
Pens vs. Vials and the Impact of Convenience and Greater Dosing Accuracy
Cost Comparison of Human Growth Hormone Agents Per Quarter Considering Rebates
Discussion of Two Agents vs. One Agent on Formulary
* PTP video clips play in windows media
player. To download
click here,
Mac users
click here.